Skip to main content
OpenTrials
Completed

NCT Number: NCT01942824

Adult Influenza Vaccination Text Message Reminders

Influenza infection leads to on average 24,0000 deaths and 150,000 hospitalizations annually. While vaccination is the cornerstone of preventing influenza infection, vaccination coverage in adults is low with only 35% vaccinated by end of November. Latino adults have the lowest coverage rates. Text message reminders have been used successfully for improving influenza vaccination for children. This study will assess the use of text messaging to improve influenza vaccination coverage rates in a largely minority, publicly insured adult population.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Influenza Vaccination Infections Influenza, Human Orthomyxoviridae Infections RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Columbia University

New York, 10032, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • > or = 18 years of age,
  • at least one visit to the AIM clinic during the previous year
  • a cell phone number in the registration system
  • fluent in English or Spanish. Exclusion criteria

Exclusion criteria

  • Receipt of influenza vaccination during the 2013-2014 influenza season prior to randomization.

Treatment and study plan

Text Messages

Behavioral

Primary outcomes

  1. Timeliness of vaccination

    Time frame: 6 months

    Days from start of intervention to vaccination

Secondary outcomes

  1. Receipt of influenza vaccine dose

    Time frame: 15 weeks

    Proportion of individuals in each group receiving an influenza dose by December 31, 2013

  2. Receipt of Influenza vaccine dose, end of season

    Time frame: 28 weeks

    Proportion of individuals in each group receiving an influenza dose by March 31st, 2014

Sponsors and collaborators

Lead sponsor

Columbia University

Other

Registry information

Important dates

Study start
2013
Primary completion
2014
Study completion
2014
First posted
Sep 16, 2013
Registry last updated
Jun 24, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.